Clinical Trial Update: PPI-amoxicillin for H. Pylori Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for PPI-amoxicillin in treating Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• PPI-amoxicillin (PPI-amoxicillin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN